Literature DB >> 10558909

Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms.

S Yoon1, G Tromp, S Vongpunsawad, A Ronkainen, T Juvonen, H Kuivaniemi.   

Abstract

MMP3, MMP9, and PAI-1 are present at increased levels in abdominal aortic aneurysms (AAAs). The promoters of these genes contain polymorphisms, with alleles that exhibit different transcriptional activities in vitro. Association studies were performed using these polymorphisms and DNA isolated from 47 AAA patients, 57 intracranial aneurysm (IA) patients, and 174 controls, all from Finland. PAI-1 and MMP9 genotypes did not associate with aneurysms. The frequency of the 5A MMP3 allele was somewhat higher in the AAA than that in the control group (P = 0.0609 after Bonferroni correction), whereas the MMP3 allele frequencies in the IA group did not differ from those of the controls (P = 0.9667). These findings suggest that the transcriptionally more active 5A MMP3 allele might be a genetic risk factor for AAA among Finns. They are in agreement with previous studies demonstrating higher level of MMP3 expression in AAA than in control tissues. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558909     DOI: 10.1006/bbrc.1999.1721

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms).

Authors:  I Omer Barlas; Melek Sezgin; M Emin Erdal; Günsah Sahin; Handan Camdeviren Ankarali; Zühal Mert Altintas; Ebru Türkmen
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

3.  No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage.

Authors:  Sandra Olsson; Ludvig Z Csajbok; Katarina Jood; Karin Nylén; Bengt Nellgård; Christina Jern
Journal:  J Neurol       Date:  2011-07-07       Impact factor: 4.849

4.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.

Authors:  Young Mi Hong; Hyun-Seung Jin; In Sook Park; Soo-Jong Hong
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

6.  Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm.

Authors:  Li-Juan Li; Xin-Min Pan; Xiutian Sima; Zhao-Hui Li; Lu-Shun Zhang; Hong Sun; Yi Zhu; Wei-Bo Liang; Lin-Bo Gao; Lin Zhang
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

7.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Authors:  Robert C Kaplan; Nicholas L Smith; Stanley Zucker; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

8.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

9.  Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Authors:  Ajay K Chaudhary; Mamta Singh; Alok C Bharti; Mangal Singh; Shirish Shukla; Atul K Singh; Ravi Mehrotra
Journal:  BMC Cancer       Date:  2010-07-14       Impact factor: 4.430

10.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.